Adam has been accepted to Mount Sinai’s Elementa Labs as a member of its 2022 cohort, according to a May 9 press release. The program will help the company optimize, expand, commercialize and advance its technology for its 3D-bioprinting platform.
“Adam team is excited to start Elementa Labs, as it is a significant milestone for the company,” said Denys Gurak, CEO of Adam. “The program will provide guidance for potential commercialization of our technology in the U.S.”
Elementa Labs, launched June 8, connects digital health startups to Mount Sinai’s subject matter experts, who provide the companies with expertise, resources and access to key stakeholders.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
